Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cullinan Management (CGEM – Research ...
New Stocks Added to the Biotech Directories : Camp4 Therapeutics Corp (Nasdaq:CAMP ) is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein ...